Farms.com Home   News

FCL and AGT Foods Announce Joint Venture for Western Canada

Federated Co-operatives Limited and AGT Foods are partnering up for a key project for Western Canada.

FCL announced plans for the construction of a $2 billion Integrated Agriculture Complex (IAC) north of the Co-op Refinery Complex in Regina.

Scott Banda, CEO of FCL, says this new complex represents another step in their strategy to adapt to the challenges of a low carbon economy.

"It will ensure that we are producing the transportation fuels to meet consumer needs, while creating jobs, economic prosperity and value-added agriculture production for the benefit of the over 600 communities that Co-op serves across Western Canada."

The new complex will include two components, a renewable diesel fuel plant, and a canola crushing plant.

Banda announced a joint venture partnership with AGT Foods in the construction of a $360 million canola crushing facility at the site.

The new 1.1 million tonne crush facility will provide about 50% of the feed stock required for the 15,000 barrel per day renewable diesel plant.

Banda says both companies believe in ensuring they maximize the potential of value-added opportunities to the benefit of Western Canada.

Murad Al-Katib, President and CEO of AGT Foods, says bringing our infrastructures together provide great leadership and great opportunities for this project.

"We believe that Agriculture is at the forefront of many global challenges, and its increasing becoming a part of society's solution to global protein, food and renewable fuel supplies."

He says the fields of Western Canada's farmers are akin to the oil fields of oil producing nations, but our fields renew annually with each new crop.

"The fields of canola provide a source for production and renewable fuels. They are renewable themselves and contribute positively to both climate change and carbon related initiatives, while combined with nitrogen fixing crops like pulses. At the end of the day, these provide great opportunities for local communities."

Saskatchewan Premier Scott Moe says this is a tremendous opportunity for Saskatchewan and for FCL and AGT Foods, that will bolster the sustainability and economic goals of these companies and the province.

"Our province has the food, fertilizer, and fuel the world needs, including renewable energy from canola grown and processed here, which speaks to the heart of our plan for economic recovery and growth as we work to build an independent, strong and sustainable Saskatchewan."

The FCL-AGT canola crushing facility will ensure Saskatchewan exceeds its 2030 Growth Plan goal of processing 75 per cent of the canola grown in the province. It also supports the Growth Plan goal of increasing agriculture value-added revenue to $10 billion.

The new 1.1 million metric tonne crush facility will provide about 50% of the feed stock required for the 15,000 barrel per day renewable diesel plant.

The new renewable diesel plant is expected to be operational in 2027.

Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.